Key result
Pleuropericardial effusion can be an atypical initial presentation of lupus mimicking infection and requiring escalating immunosuppression.
Why the study?
Pleuropericardial effusions as an initial presentation of systemic lupus erythematosus pose diagnostic and treatment challenges due to symptom overlap with infections and variable response to glucocorticosteroids.
Case Report (n=1)
Pleuropericardial effusion is a challenging initial presentation of SLE that mimics infection, highlighting the need for careful differential diagnosis and individualized immunosuppressive therapy.
Alerts clinicians to consider SLE in infection-mimicking effusions; leaves open optimal escalation strategies for recurrent serositis.
Systemic lupus erythematosus is a multisystem autoimmune disease with varied manifestations involving pulmonary features of pleuritis and pericarditis. These complications may be difficult to diagnose in early stages, as they mimic infectious symptoms. The paper sheds light on diagnostic and treatment challenges associated with lupus pleuropericardial effusions. Glucocorticosteroids (GCs) are usually the first-line treatment, but some patients do not respond to this therapy and require escalation to immunosuppressants or biologics. This is review based on studies published in peer-reviewed journals within past 20 years. The case of a patient with pleural effusion included in the article, in whom the diagnosis of SLE was made through the diagnosis of infection, as well as the cases from the available literature presented in the discussion, well illustrate the problem of symptoms that are part of the picture of SLE, but are non-specific and require differential diagnosis. Early diagnosis and treatment with immunosuppressive, immunemodulating drugs and biologics may lead to better outcomes; further research is needed to explore therapeutic options in difficult cases.
No takes yet. Share an insight, caveat, or question.
Bakhsh et al. (2026) conducted a case report in Systemic lupus erythematosus (SLE) (n=1). Immunosuppressive therapy (glucocorticosteroids, hydroxychloroquine, mycophenolate mofetil) was evaluated. Pleuropericardial effusion can serve as an atypical first presentation of systemic lupus erythematosus that mimics infection and often requires individualized, escalating immunosuppressive therapy to manage recurrent serositis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: